An interventional study of Snap in Arrhythmia, sponsored by The First Affiliated Hospital with Nanjing Medical University. Status unknown at 2 sites in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-07-28.
Sponsored by The First Affiliated Hospital with Nanjing Medical University · Not applicable, Interventional, and Diagnostic
Among 46 studies in Arrhythmias, Cardiac with a site in China — 21 open to participants now, 24 under way, none of them phase 3. Arrhythmias, Cardiac · China.
Among the 46 studies in Arrhythmias, Cardiac with a site in China, this one is the 15th largest by planned enrollment of the 27 interventional ones, is one of 2 that started in 2018, is one of 20 with no phase, and was the 10th registered.
1,051 studies on the registry are indexed under Arrhythmias, Cardiac; 236 are open to participants now.
This study's planned enrollment of 120 is above the median of 100 across 517 interventional studies indexed under Arrhythmias, Cardiac.
Browse Arrhythmias, Cardiac studies →21 of the 46 studies in Arrhythmias, Cardiac with a site in China are open now, in 12 countries. Each count lists the studies.
Of the 167 Arrhythmias, Cardiac studies recruiting now, 118 (71%) set no upper age limit and 13 (8%) stop at 75 or younger; 31 take children under 18; 26 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →46 studies; the count open now beside each. This study's row is marked.
First in 1983; this study’s year is marked. 2 started in 2018.
Median enrollment 130 across the 27 interventional studies, 1,000 across the 19 observational. Of the 16 that completed or were terminated, 6 (38%) have results posted.
13 of 46 have an industry lead sponsor. The 10 most frequent:
The First Affiliated Hospital with Nanjing Medical University is the lead sponsor of 568 studies on the registry; 317 are open to participants now.
The First Affiliated Hospital with Nanjing Medical University has 3 studies filed under Arrhythmias, Cardiac — fewer than ten, so there is no comparison to draw.
5 of the studies in Arrhythmias, Cardiac with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05694273First Affiliated Hospital Xi'an Jiaotong UniversityAcute Cerebrovascular Events in Patients Undergoing Catheter Ablation | 2026-12-01 |
| NCT07390513Chinese Academy of Medical Sciences, Fuwai HospitalElectrophysiological Outcomes After Transcatheter Aortic Valve Replacement | 2026-12-31 |
| NCT07669493Hebei Medical University Fourth HospitalCardiac Safety Management and Immune Microenvironment Changes After Thoracic Radiotherapy: A Prospective Observational Study | 2027-01-01 |
| NCT06984731Affiliated Hospital of Nantong UniversityThe Safety and Efficacy of Radiofrequency Ablation After Left Atrial Appendage Occlusion. | 2027-06-01 |
| NCT07217067Novartis PharmaceuticalsA Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation | 2027-09-09 |
Among the 46 studies in Arrhythmias, Cardiac with a site in China, from their registry updates:
Nothing recorded among them since 2026-09-25.
Participants in the Snap arm were instructed to undertake once-day recording and transmission of a 30-second single-lead iECG trace to a secure server, plus additional submissions if symptomatic over a 3-month period. Snap traces were analyzed by an automated analysis software and cardiologists. Clinical review and appropriate care was arranged for those clinically significant arrhythmia. Patients in the RC group were followed up as normal methods including ECG, Holter.
Individuals with symptomatic arrhythmia without known arrhythmia were recruited.
Participants were required to have access to the internet via WiFi and to be able to operate the Snap system after simple instruction. Written consent was obtained, and eligible participants were randomized (1:1) to an intervention (Snap) group or RC group.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
individuals in this arm used Snap according to the instruction on time and screened at the symptomatic
Diagnostic Test: Snap
patients in the RC arm accepted normal methods
screen, transmission, and analysis ECG automated
Evaluating the ability of handheld device with remote interpretation to screen for arrhythmia
Participants in Snap group acquired ECG once od according to the rules and transmitted ECG immediately once symptom appeared between 3-month. Patients in the routine treatment (RT) group were administrated normal diagnostic techniques. At 3-month, compared the incidence atrial arrhythmia(atrial premature beats and atrial tachycardia) and ventricula arrhythmia(ventricular premature beats and ventricular tachycardia) between two groups.
Time frame: 3-month
Evaluating the patients' quality of life
Using RAND 36-Item Short Form Health Survey (SF-36) 1.0 Questionnaire items assessed the quality of life of participants. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability. To calculate the scores it is necessary to purchase special software. Pricing depends on the number of scores that the researcher needs to calculate. The eight sections are: vitality, physical functioning, bodily pain, general, health perceptions, physical role functioning, emotional role functioning, social role functioning, mental health. The total scale ranges from 35 to 145. The higher the total score, the better the patient's quality of life.
Time frame: 3-month
Plan to share: Undecided
Started Oct 2018 (actual). Primary completion is estimated for Nov 2020, 25 months after the start.
Of 171 non-industry interventional studies with no phase under Arrhythmias, Cardiac, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 43. This study's planned 25 months is below that.
Counting every sponsor, half of 242 studies reached it within 24 months; a quarter within 12 and three quarters within 40.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The First Affiliated Hospital with Nanjing Medical University →